Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall recurrence and treatment failure. Patients with HRR-deficient metastatic ...

Cases of prostate cancer are on the rise in California ... is now available and is poised to spare men with low risk disease from unnecessary treatment while ensuring early detection for men ...

Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to ...

Testosterone therapy after prostate cancer surgery does not appear to increase biochemical recurrence (BCR) risk in patients with low-risk disease, investigators report.

A mobile prostate cancer screening program proved feasible for men in underserved neighborhoods and led to a high rate of ...

Radiotherapy, a standard of care treatment for localized prostate cancer includes, has shown remarkable success. This ...

New research maps the global burden of male cancers from 1990 to 2040, showing how aging, lifestyle, and healthcare access ...

The current gold-standard test for prostate cancer is the prostate-specific antigen (PSA ... Researchers plan to study the ...

“This procedure is kind of focused on guys that are in between and have intermediate to low-risk prostate cancer,” Jacobs said. “We do a non-invasive treatment that uses ultrasound to target ...

A nurse-led mobile healthcare clinic identified a high proportion of clinically significant prostate cancers among men from ...

said in a news release. Findings also show that if cancer develops in the high-risk state, it’s more likely to be a solid ...

New Data at ASCO GU Show Power of Veracyte’s Decipher Tests to Improve Patient Care and Its GRID Tool to Advance Prostate and ...